| 标题 |
Current regulatory status in China of drugs withdrawn from the US FDA accelerated pathway: implications for regulation globally |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Oncology 作者:Xingxian Luo; Lin Huang; Xin-Li Du; Yue Yang; Xufeng Lv; et al 出版日期:2024-06-01 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)